SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001683168-19-001341
Filing Date
2019-05-02
Accepted
2019-05-02 17:27:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D fatih_sc13d.htm SC 13D 34395
  Complete submission text file 0001683168-19-001341.txt   35761
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Subject) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45691 | Film No.: 19793231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 701 GATEWAY BOULEVARD, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address
Uckun Fatih (Filed by) CIK: 0001774151 (see all company filings)

Type: SC 13D